Organon Biosimilars is here for you every step of the way
Deciding, implementing, and monitoring the adoption of a biosimilar can seem daunting, but Organon Biosimilars is here to help you identify the various steps involved.
Roadmap for health care professionals for considering, implementing, and monitoring biosimilar adoption in an institution.Download
Roadmap for health care professionals for considering, implementing, and monitoring biosimilar adoption in a private practice setting.Download
Before adding any medicine onto formulary, nearly every organization relies on its pharmacy and therapeutics (P&T) committee to conduct a broad and detailed evaluation of the product, including biosimilars.
Key elements of biosimilar formulary review:
- Indication, MOA, and dosing and administration
- Clinical efficacy and safety
- Supply chain
- Patient/Provider education
- Tracking and information system implications
What should health system pharmacists know about biosimilars?
Advocating for Biosimilars
Interactive educational resource for pharmacists exploring the potential value biosimilars may bring to the health care system.
Interactive educational resource for pharmacists overviewing clinical considerations for biosimilars.